Growing literature has shown heterogenous effects of conditional cash incentives (CCIs) on HIV care retention. The field lacks insights into reasons why incentives impact various patients in different ways–differences that may be due to variations in psychological and social mechanisms of effect. A deeper understanding of patients’ perceptions and experiences of CCIs for retention may help to clarify these mechanisms. We conducted a qualitative study embedded in the ADAPT-R trial (NCT#02338739), a sequential multiple assignment randomized trial (SMART) that evaluated economic incentives to support retention in HIV care among persons living with HIV (PLHIV) initiating antiretroviral therapy in Kenya. Participants who attended their scheduled...
<div><p>Background</p><p>Tools from behavioral economics have been shown to improve health-related b...
Background: There has been growing interest in the use of incentives to increase the uptake of heal...
With the introduction of Highly Active Anti-Retro Viral Therapy (HAART), Human Immunodeficiency Viru...
Growing literature has shown heterogenous effects of conditional cash incentives (CCIs) on HIV care ...
Financial and in-kind incentives have been shown to improve outcomes along the HIV care cascade, how...
BackgroundViral suppression among people living with HIV (PLHIV) is essential for protecting health ...
BACKGROUND:Cash and in-kind incentives can improve health outcomes in various settings; however, the...
<div><p>Background</p><p>Cash and in-kind incentives can improve health outcomes in various settings...
Introduction Conditional economic incentives are shown to promote medication adherence across a rang...
BACKGROUND: HPTN 065 (TLC-Plus) evaluated the feasibility and effectiveness of providing quarterly $...
Interventions to improve antiretroviral therapy (ART) access are urgently needed to maximize the mul...
Background. Drug users (DUs), a population that accounts for some of the fastest-growing human immun...
BACKGROUND: Financial incentives promote use of HIV services and might support adherence to the sust...
BACKGROUND:HPTN 065 (TLC-Plus) evaluated the feasibility and effectiveness of providing quarterly $7...
HPTN 065 (TLC-Plus) evaluated the feasibility and effectiveness of providing quarterly $70 gift card...
<div><p>Background</p><p>Tools from behavioral economics have been shown to improve health-related b...
Background: There has been growing interest in the use of incentives to increase the uptake of heal...
With the introduction of Highly Active Anti-Retro Viral Therapy (HAART), Human Immunodeficiency Viru...
Growing literature has shown heterogenous effects of conditional cash incentives (CCIs) on HIV care ...
Financial and in-kind incentives have been shown to improve outcomes along the HIV care cascade, how...
BackgroundViral suppression among people living with HIV (PLHIV) is essential for protecting health ...
BACKGROUND:Cash and in-kind incentives can improve health outcomes in various settings; however, the...
<div><p>Background</p><p>Cash and in-kind incentives can improve health outcomes in various settings...
Introduction Conditional economic incentives are shown to promote medication adherence across a rang...
BACKGROUND: HPTN 065 (TLC-Plus) evaluated the feasibility and effectiveness of providing quarterly $...
Interventions to improve antiretroviral therapy (ART) access are urgently needed to maximize the mul...
Background. Drug users (DUs), a population that accounts for some of the fastest-growing human immun...
BACKGROUND: Financial incentives promote use of HIV services and might support adherence to the sust...
BACKGROUND:HPTN 065 (TLC-Plus) evaluated the feasibility and effectiveness of providing quarterly $7...
HPTN 065 (TLC-Plus) evaluated the feasibility and effectiveness of providing quarterly $70 gift card...
<div><p>Background</p><p>Tools from behavioral economics have been shown to improve health-related b...
Background: There has been growing interest in the use of incentives to increase the uptake of heal...
With the introduction of Highly Active Anti-Retro Viral Therapy (HAART), Human Immunodeficiency Viru...